Novartis Vas Narasimhan - Search Videos

Watch CNBC's full interview with Novartis CEO Vas Narasimhan

Watch CNBC's full interview with Novartis CEO Vas Narasimhan

Watch CNBC's full interview with Novartis CEO Vas Narasimhan on evolving through Covid

Watch CNBC's full interview with Novartis CEO Vas Narasimhan on evolving through Covid

Watch CNBC's full interview with Novartis CEO Vas Narasimhan on earnings and weight loss drugs

Watch CNBC's full interview with Novartis CEO Vas Narasimhan on earnings and weight loss drugs

Watch CNBC's full interview with Novartis' Vas Narasimhan

Watch CNBC's full interview with Novartis' Vas Narasimhan

Own the role you have: How Vas Narasimhan accelerated his rise to Novartis CEO

Own the role you have: How Vas Narasimhan accelerated his rise to Novartis CEO

Vasant Narasimhan, Novartis CEO, discusses the impact of potential tariffs. Watch more of the interview: cnb.cx/42z5GHP | CNBC

Vasant Narasimhan, Novartis CEO, discusses the impact of potential tariffs. Watch more of the interview: cnb.cx/42z5GHP | CNBC

9K viewsApr 29, 2025

Vas Narasimhan: The Indian-Origin Novartis CEO Driving the Future of AI-Powered Healthcare

Vas Narasimhan: The Indian-Origin Novartis CEO Driving the Future of AI-Powered Healthcare

Novartis CEO Vas Narasimhan discusses how they maintain profit when a patented drug becomes a "generic" after 17 years. Watch this episode of "The David Rubenstein Show: Peer-to-Peer Conversations" tonight at 9 pm ET via our link in bio | Bloomberg Television

195 viewsMar 6, 2024

FacebookBloomberg Television

Novartis CEO Vas Narasimhan speaks to BTV at Davos

Anthropic’s oversight trust just hit majority control. The tipping-point was adding Novartis CEO Vas Narasimhan to its board

rdworldonline.com

Novartis ‘focusing on high-end, innovative medicines,’ CEO says

YahooYahoo Finance Video

Growth guidance remains 'fully intact,’ says Novartis CEO Vas Narasimhan

Novartis CEO Vasant Narasimhan on building trust with society

Novartis in wait-and-watch mode for Indian pharma market, CEO Vas Narasimhan says

Novartis CEO Vas Narasimhan discusses his outlook for the second half of the year, the vaccine rollout and the long-term impact of #Covid19. Read more: https://bit.ly/36QlNTY | NDTV Profit

434K viewsFeb 6, 2021

FacebookNDTV Profit

Novartis CEO: Here's why we boosted our full-year guidance

Novartis CEO Vas Narasimhan: Expect solid growth this year top and bottom line

CNBCAngelica Peebles

Our CEO, Vas Narasimhan, shares his vision for Novartis’ future as a more focused medicines company. http://bit.ly/2Vw8PDf | Novartis

11.3K viewsApr 9, 2019

FacebookNovartis

Anthropic adds Novartis CEO Vas Narasimhan to its board

Novartis CEO joins Anthropic board of directors

marketscreener.com

Novartis CEO: We're never done with M&A

Focus remains on R&D to drive growth of blockbuster drugs, says Novartis CEO

Novartis CEO Vas Narasimhan: 'We really should be talking about out-of-pocket costs' in the US

Nun verdient Vas Narasimhan 25 Millionen. Der Novartis-Chef hat aber auch so noch viel vor

Novartis CEO explains 'prudent' 2024 guidance

Novartis CEO Vasant Narasimhan on earnings and the company's response to Covid-19

Vas Narasimhan never thought he would become a CEO. “The idea only fully occurred to me six months before I became CEO of Novartis,” the head of the pharmaceutical giant told CNBC's Steve Sedgwick on the

224 views2 months ago

Committed to growing over 4% through 2026, says Novartis CEO

Talking culture transformation with Vas Narasimhan and Adam Grant

100.8K viewsJun 25, 2019

YouTubeNovartis

Tariffs are an overhang on pharma sector, but we will comeback, says Novartis CEO Vas Narasimhan

See more